ADKO

evidence-of-injury-mwm-1

6 min read

This document presents evidence and arguments regarding potential adverse reactions and deaths following COVID-19 vaccine administrations, drawing parallels to historical vaccine issues. It is structured to cover:

  1. Historical Precedents: Examples of previously licensed vaccines that caused injuries or were suspended after being marketed, suggesting that adverse events might not be immediately apparent.
  2. VAERS (Vaccine Adverse Events Reporting System): An explanation of VAERS and studies indicating significant underreporting of adverse events.
  3. COVID-19 Vaccine Data: Presentation of data on adverse events, including deaths, reported to VAERS for COVID-19 vaccines.
  4. International Data: Adverse event reports from the UK, EU, WHO, and Israel, noting over one million reports worldwide.
  5. Blood Clot Reports: Focus on blood-clot related adverse events in the US, UK, and EU.
  6. News and Social Media Reports: Clippings of reported adverse events.
  7. Possible Mechanisms of Harm: Discussion of potential biological pathways by which COVID-19 vaccines might cause adverse reactions.

The document highlights several past vaccine issues, including the Sanofi Pasteur Dengue Virus vaccine, the GSK 2009 H1N1 “swine flu” vaccine causing narcolepsy, polio vaccine contamination with SV-40, the Rotavirus vaccine withdrawal due to intussusception, the 1976 Swine Flu vaccination campaign halt due to Guillain-Barré syndrome, the Trivirix MMR vaccine withdrawal for aseptic meningitis, and the Cutter Incident with live polio virus. It also criticizes the Bill & Melinda Gates Foundation’s role in vaccine promotion, citing concerns about financial conflicts of interest and alleged unethical practices in HPV vaccine trials. Additionally, it mentions WHO and UNICEF distributing tetanus vaccines contaminated with an anti-fertility hormone in Kenya.

Regarding VAERS, the document cites studies suggesting underreporting rates of 80-94% for adverse events and less than 1% for serious vaccine adverse events. It presents COVID-19 vaccine data as of May 14, 2021, showing 4,201 reported deaths (with an estimated higher range) and 227,805 total adverse event reports, with significant numbers categorized as serious, requiring hospitalization, life-threatening, or causing permanent disability. The document notes that COVID-19 vaccine deaths constituted 34% of all VAERS deaths by that date, with a higher reported death rate compared to the flu vaccine.

UK Yellow Card reports up to May 5, 2021, show 1,173 deaths and 224,544 reports, with numerous adverse reactions listed for Pfizer and AstraZeneca vaccines across various systems. European Adverse Events Monitoring Agency (EUDRAVIGILANCE) data as of May 8, 2021, reports 10,811 deaths and 463,476 reports.

The WHO’s VigiBase database has over 10 million reports globally as of May 25, with the Americas and Europe accounting for a significant portion. Israel’s adverse events reporting is described as inadequate and non-transparent. An Israeli Health Ministry investigation reportedly found an elevated rate of heart inflammation (pericarditis, myopericarditis, and myocarditis) in young adults after Pfizer vaccination.

The document also discusses increased mortality rates observed after vaccination drives in some regions, particularly among older populations, and questions whether this is a delayed effect of vaccinations.

Reports of “rare” blood clots, specifically thrombosis with thrombocytopenia (TTS), are highlighted, leading to suspensions or investigations of AstraZeneca and Janssen (Johnson & Johnson) vaccines. The UK’s MHRA identified 262 cases of TTS with AstraZeneca, including 51 deaths. The document criticizes the focus on TTS while potentially ignoring a “HUGE number of reports of other types of blood clots,” presenting data showing 29,568 blood-clot related adverse events and 2,395 associated deaths across US, EU, and UK reporting systems. It notes blood clots were reported for Pfizer, Moderna, J&J, and AstraZeneca vaccines.

Possible mechanisms for harm discussed include allergic reactions to PEGylated Lipid Nanoparticles (given that many individuals have pre-existing anti-PEG antibodies), Antibody-Dependent Enhancement (ADE), Epitope Homology and Molecular Mimicry where antibodies to the SARS-CoV-2 spike protein might attack human proteins, and the potential for the spike protein itself to cause microvascular injury to organs like the brain, heart, liver, and kidneys.

The document concludes by expressing concerns about the long-term safety of COVID-19 vaccines, given the limited duration of trials and the potential for devastating, lifelong injuries, suggesting that it will be difficult for individuals to receive compensation for vaccine injuries.

Key Entities, Locations, and References Mentioned:

Graph View